Valneva SE (EPA:VLA)
2.710
-0.112 (-3.97%)
Apr 2, 2026, 5:35 PM CET
Valneva SE Market Cap
Valneva SE has a market cap or net worth of €470.87 million as of April 2, 2026. Its market cap has decreased by -12.67% in one year.
Market Cap
470.87M
Enterprise Value
568.47M
Revenue
174.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.71
Market Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 99.08M to 470.87M, an increase of 375.25%. That is a compound annual growth rate of 8.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 470.87M | -26.69% |
| Dec 31, 2025 | 642.32M | 82.94% |
| Dec 31, 2024 | 351.10M | -46.40% |
| Dec 29, 2023 | 655.08M | -23.93% |
| Dec 30, 2022 | 861.12M | -66.55% |
| Dec 31, 2021 | 2.57B | 265.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.33B |
| DBV Technologies | 1.01B |
| Inventiva | 901.67M |
| MedinCell | 829.39M |
| Genfit | 429.73M |
| Cellectis | 225.40M |
| Sensorion | 215.15M |
| Transgene | 202.63M |